跳至主要内容
临床试验/NL-OMON21162
NL-OMON21162尚未招募不适用

Treatment of stage I non-small cell lung cancer: designing information for patient participation in decision making.

未提供0 个研究点目标入组 25 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
25

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Adult patients with early stage lung cancer who are scheduled to undergo SABR treatment;
  • 2. Written informed consent according to local medical ethical committee regulations.

排除标准

  • 1. Patients who are unable to speak and understand the Dutch or English language;
  • 2. Patients who are unable to provide informed consent.

研究者

发起方
未提供

相似试验

Designing information for lung cancer patients in... | 临床试验